key: cord-0921356-p1vc2p5q authors: Giustino, Gennaro; Croft, Lori B.; Stefanini, Giulio G.; Bragato, Renato; Silbiger, Jeffrey J.; Vicenzi, Marco; Danilov, Tatyana; Kukar, Nina; Shaban, Nada; Kini, Annapoorna; Camaj, Anton; Bienstock, Solomon W.; Rashed, Eman R.; Rahman, Karishma; Oates, Connor P.; Buckley, Samantha; Elbaum, Lindsay S.; Arkonac, Derya; Fiter, Ryan; Singh, Ranbir; Li, Emily; Razuk, Victor; Robinson, Sam E.; Miller, Michael; Bier, Benjamin; Donghi, Valeria; Pisaniello, Marco; Mantovani, Riccardo; Pinto, Giuseppe; Rota, Irene; Baggio, Sara; Chiarito, Mauro; Fazzari, Fabio; Cusmano, Ignazio; Curzi, Mirko; Ro, Richard; Malick, Waqas; Kamran, Mazullah; Kohli-Seth, Roopa; Bassily-Marcus, Adel M.; Neibart, Eric; Serrao, Gregory; Perk, Gila; Mancini, Donna; Reddy, Vivek Y.; Pinney, Sean P.; Dangas, George; Blasi, Francesco; Sharma, Samin K.; Mehran, Roxana; Condorelli, Gianluigi; Stone, Gregg W.; Fuster, Valentin; Lerakis, Stamatios; Goldman, Martin E. title: Characterization of Myocardial Injury in Patients With COVID-19 date: 2020-11-03 journal: J Am Coll Cardiol DOI: 10.1016/j.jacc.2020.08.069 sha: 118bd563ad92b3a23ff70768e8d85893761588d8 doc_id: 921356 cord_uid: p1vc2p5q BACKGROUND: Myocardial injury is frequent among patients hospitalized with coronavirus disease-2019 (COVID-19) and is associated with a poor prognosis. However, the mechanisms of myocardial injury remain unclear and prior studies have not reported cardiovascular imaging data. OBJECTIVES: This study sought to characterize the echocardiographic abnormalities associated with myocardial injury and their prognostic impact in patients with COVID-19. METHODS: We conducted an international, multicenter cohort study including 7 hospitals in New York City and Milan of hospitalized patients with laboratory-confirmed COVID-19 who had undergone transthoracic echocardiographic (TTE) and electrocardiographic evaluation during their index hospitalization. Myocardial injury was defined as any elevation in cardiac troponin at the time of clinical presentation or during the hospitalization. RESULTS: A total of 305 patients were included. Mean age was 63 years and 205 patients (67.2%) were male. Overall, myocardial injury was observed in 190 patients (62.3%). Compared with patients without myocardial injury, those with myocardial injury had more electrocardiographic abnormalities, higher inflammatory biomarkers and an increased prevalence of major echocardiographic abnormalities that included left ventricular wall motion abnormalities, global left ventricular dysfunction, left ventricular diastolic dysfunction grade II or III, right ventricular dysfunction and pericardial effusions. Rates of in-hospital mortality were 5.2%, 18.6%, and 31.7% in patients without myocardial injury, with myocardial injury without TTE abnormalities, and with myocardial injury and TTE abnormalities. Following multivariable adjustment, myocardial injury with TTE abnormalities was associated with higher risk of death but not myocardial injury without TTE abnormalities. CONCLUSIONS: Among patients with COVID-19 who underwent TTE, cardiac structural abnormalities were present in nearly two-thirds of patients with myocardial injury. Myocardial injury was associated with increased in-hospital mortality particularly if echocardiographic abnormalities were present. C oronavirus disease-2019 (COVID- 19) is a global pandemic caused by the novel severe acute respiratory syndrome-coronavirus-2 that is resulting in substantial morbidity and mortality (1) . A significant proportion of patients presenting with COVID-19 infection requiring hospitalization have biomarker evidence of myocardial injury, which has been shown to be associated with increased risk of in-hospital morbidity and mortality (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . The pathogenesis of myocardial injury in patients affected by COVID-19 remains unclear. Proposed mechanisms include cytokinemediated damage, oxygen supply-demand imbalance, ischemic injury from microvascular thrombi formation and direct viral invasion of the myocardium (9, 11) . In addition, the risk of coronary thrombotic events from atherosclerotic plaque rupture has previously been shown to be increased during viral infections (12, 13) , although a reduction in the numbers of patients presenting to hospitals with acute coronary syndromes (ACSs) has thus far been described with COVID-19 (14, 15) . Previous published series have defined myocardial injury only on the basis of myocardial necrosis biomarker elevations without imaging to characterize structural and functional cardiac abnormalities (2, 3, 9) . In this regard, performing an extensive cardiac work-up in patients with COVID-19 is logistically challenging due to their clinical status and the need to High-sensitivity cardiac troponin T, ng/l Myocardial Injury in COVID-19 Table 2) . Patients with myocardial injury also had greater LV volumes, wall thickness, and left atrial volumes. The relationships among ECG changes, clinical presentation, and echocardiographic characteristics are reported in Table 3 and Supplemental Table 9 . Patients with ST-segment changes more frequently had chest pain at the time of presentation and, among these patients, those with regional ST-segment changes had higher degrees of troponin elevations. Figure 1B) . As shown in Figure 2 , by multivariable analysis, mortality was increased in patients with myocardial injury and echocardiographic abnormalities even after adjust- Table 12 ). In-hospital outcomes in patients with myocardial injury and major echocardiographic abnormalities are reported in Supplemental Any pericardial effusion 20 (7.3) 2 (9.1) 0 (0.0) 0.69 Values are n (%) or median (interquartile range) as appropriate. *Defined as ST-segment elevations or deviations occurring in a coronary artery distribution territory, including reciprocal ST-segment changes. Abbreviations as in Table 2 . Giustino et al. regional ST-segment changes associated with regional wall motion abnormalities (possibly reflecting regional ischemic damage of the myocardium due to macro-or microvascular thrombosis). Therefore, By multivariable analysis, myocardial injury in patients with major echocardiographic abnormalities was strongly associated with increased risk for inhospital mortality, even after correcting for other major COVID-19-related complications such as ARDS, AKI, and cardiocirculatory shock (which themselves were also independent predictors of mortality). Conversely, myocardial injury without major echocardiographic abnormalities was not a significant predictor of increased mortality. Thus, TTE in patients with troponin-positive COVID-19 syndromes provides useful prognostic information. The association between myocardial injury and mortality (especially in those with echocardiographic abnormalities) has been shown to broadly affect the cardiovascular system (18 Results are reported as odds ratios (ORs) and 95% confidence intervals (CIs). The following variables were included in the final model: age, sex, race, history of heart failure, acute respiratory distress syndrome, acute kidney injury stage II or III, cardiocirculatory shock, myocardial injury (with or without major echocardiographic abnormalities), and center identifier. *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction, or presence of mild or more severe pericardial effusion. is subject to both reporting and ascertainment bias. Our sample size is modest but nonetheless repre- Covid-19-navigating the uncharted Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Acute myocardial injury in patients hospitalized with COVID-19 infection: a review The impact of 2019 novel coronavirus on heart injury: a systematic review and meta-analysis Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis Acute myocardial infarction after laboratory-confirmed influenza infection ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic Acute respiratory distress syndrome: the Berlin definition KDIGO clinical practice guideline for acute kidney injury COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies for the Executive Group for ESC/ACC/AHA/WHF. Fourth universal definition of myocardial infarction KEY WORDS COVID-19, echocardiography, myocardial infarction, myocardial injury APPENDIX For supplemental tables and references, please see the online version of this paper